Related Experiment Video
Updated: Jul 4, 2026

Production of Genetically Engineered Golden Syrian Hamsters by Pronuclear Injection of the CRISPR/Cas9 Complex
Published on: January 9, 2018
Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters
Jeanne H Schickli1, Jasmine Kaur, Mia Macphail
1Research Dept, MedImmune, Mountain View, CA 94043, USA. Schicklij@medimmune.com
Background:
Human metapneumovirus (hMPV) infection can cause acute lower respiratory tract illness in infants, the immunocompromised, and the elderly. Currently there are no licensed preventative measures for hMPV infections. Using a variant of hMPV/NL/1/00 that does not require trypsin supplementation for growth in tissue culture, we deleted the M2-2 gene and evaluated the replication of rhMPV/DeltaM2-2 virus in vitro and in vivo.
Results:
In vitro studies showed that the ablation of M2-2 increased the propensity for insertion of U nucleotides in poly-U tracts of the genomic RNA. In addition, viral transcription was up-regulated although the level of genomic RNA remained comparable to rhMPV. Thus, deletion of M2-2 alters the ratio between hMPV genome copies and transcripts. In vivo, rhMPV/DeltaM2-2 was attenuated compared to rhMPV in the lungs and nasal turbinates of hamsters. Hamsters immunized with one dose of rhMPV/DeltaM2-2 were protected from challenge with 106 PFU of wild type (wt) hMPV/NL/1/00.
Conclusion:
Our results suggest that hMPV M2-2 alters regulation of transcription and influences the fidelity of the polymerase complex during viral genome replication. In the hamster model, rhMPVDeltaM2-2 is attenuated and protective suggesting that deletion of M2-2 may result in a potential live vaccine candidate. A more thorough knowledge of the hMPV polymerase complex and the role of M2-2 during hMPV replication are being studied as we develop a potential live hMPV vaccine candidate that lacks M2-2 expression.
Insights
Deleting the M2-2 gene from human metapneumovirus (hMPV) created an attenuated virus. This modified hMPV (rhMPV/DeltaM2-2) protected hamsters against wild-type hMPV infection, suggesting its potential as a live vaccine candidate.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Human metapneumovirus (hMPV) causes severe respiratory illness in vulnerable populations.
- No licensed preventative measures currently exist for hMPV infections.
- Research focuses on developing novel strategies against hMPV.
Purpose of the Study:
- To investigate the role of the M2-2 gene in hMPV replication.
- To evaluate the potential of a modified hMPV lacking M2-2 as a vaccine candidate.
Main Methods:
- A variant hMPV lacking the M2-2 gene (rhMPV/DeltaM2-2) was created.
- Replication of rhMPV/DeltaM2-2 was assessed in vitro and in vivo (hamster model).
- Viral transcription, genomic RNA, and polymerase complex activity were analyzed.
Main Results:
- In vitro, M2-2 deletion altered viral transcription and RNA nucleotide insertion.
- In vivo, rhMPV/DeltaM2-2 showed significant attenuation in hamsters.
- A single dose of rhMPV/DeltaM2-2 conferred protection against wild-type hMPV challenge.
Conclusions:
- The M2-2 gene influences hMPV transcription regulation and polymerase fidelity.
- rhMPV/DeltaM2-2 is attenuated and demonstrates protective immunity in a hamster model.
- Deletion of M2-2 presents a promising strategy for developing a live hMPV vaccine.
More Related Videos
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
In-vitro Mutagenesis
Mutations in Microorganisms
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Viral Mutations

